prophylaxis – Medxy AI

Temporal Dynamics of Valacyclovir Prophylaxis in Herpes Zoster Ophthalmicus: Insights from the Zoster Eye Disease Study

By MedXY 08/16/2026

This analysis of the ZEDS trial suggests that valacyclovir prophylaxis offers temporally localized protection against recurrent ocular inflammation in herpes zoster ophthalmicus, supporting one-year suppressive therapy despite non-significant primary outcomes.

Infectious Diseases news Nursing & care

Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza Outbreaks

By MedXY 06/15/2026

Prompt oseltamivir prophylaxis covering at least 70% of eligible nursing home residents within 2 days of outbreak detection was associated with fewer hospitalizations, but not lower mortality.

Hematology-Oncology news

Long-term Outcomes in Congenital TTP: Registry Data Show Prophylactic Plasma Reduces Clinical Events but Symptoms and Product Burden Persist

By MedXY 11/15/2025

UK registry follow-up of 104 congenital TTP patients shows regular plasma prophylaxis lowers acute episodes and end‑organ events, but residual symptoms and plasma-related issues drive many patients to recombinant ADAMTS13.

Clinical Updates Hematology-Oncology news Specialties

Advances in Graft-versus-Host Disease Prophylaxis: Cyclophosphamide and Cyclosporin in Allogeneic Stem Cell Transplantation

By MedXY 08/01/2025

Post-transplant cyclophosphamide plus cyclosporin significantly improves GVHD-free, relapse-free survival compared to standard prophylaxis in matched related donor stem cell transplantation.